To verify if IFNγ was directly involved in TFF1 silencing, we used the recombinant cytokine on KATO III, a tumour cell line that expresses high levels of the gastrointestinal protein, and confirmed that the treatment with the pro-inflammatory cytokine reduces both mRNA and protein levels of TFF1. The gene discussed is IFNG; the disease is neoplasm.